Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience
Nicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam · 2026
Read Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience by Nicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473054.txt.
Description
Nicolò Ubaldi and a team of co-authors report results for a new treatment of slow-flow vessel malformations in the United Kingdom, in two thousand twenty-six. The treatment injects a drug into the lesion, then applies electric pulses to help the drug enter cells. Twenty patients with symptoms were treated at one center over about two years.
Forty-two procedures were done, most on the face. Symptom and quality-of-life scores improved clearly by follow-up, with swelling, appearance, and pain improving most. No major complications occurred. Skin marks and mouth ulcers were the main side effects, and both faded or healed. Even a single session helped, while repeated sessions helped more.
Catalog record
| CREATOR | Nicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |